1461086569-aad92e31-67fe-4b9e-9582-35a04c7fbe4a

1. A method for confirming an association with an online organization, the method comprising:
maintaining a profile in a computer memory for each of a set of users of a social networking system, wherein one or more of the users are associated with an organization;
receiving a request from a user of the social networking system to be associated with the organization, wherein the requesting user is not associated with the organization;
determining whether to grant the request based at least in part on whether the requesting user has established a connection in the social networking system with one or more other users of the social networking system who are already associated with the organization;
granting the request if the requesting user has established a connection in the social networking system with one or more other users of the social networking system who are already associated with the organization; and
updating the profile of the requesting user to indicate that the requesting user is associated with the organization if the request is granted.
2. The method of claim 1, wherein the organization comprises an online group of users.
3. The method of claim 1, wherein the organization comprises an online group of users within the social networking system.
4. The method of claim 1, wherein the organization exists outside of the social networking system.
5. The method of claim 1, wherein the organization has a real-world counterpart.
6. The method of claim 5, wherein the organization is selected from a group consisting of: a school, a college, a university, a business, and a non-profit entity.
7. The method of claim 1, wherein the connection between the requesting user and the one or more other users of the social networking system who are associated with the organization is established after receiving the request.
8. The method of claim 1, wherein the request is granted only if the user has established multiple connections in the social networking system with other users of the social networking system who are already associated with the organization.
9. The method of claim 1, further comprising:
denying the request if the requesting user has not established a connection in the social networking system with one or more other users of the social networking system who are already associated with the organization.
10. The method of claim 9, further comprising:
responsive to denying the request, inviting the requesting user to establish a connection with one or more other users of the social networking system who are already associated with the organization.
11. A method for confirming an association with an online organization, the method comprising:
maintaining a profile in a computer memory for each of a set of users of a social networking system, wherein one or more of the users are associated with an organization;
maintaining social information about the users of the social networking system;
receiving a request from a user of the social networking system to be associated with the organization, wherein the requesting user is not associated with the organization;
determining whether to grant the request based at least in part on social information about the requesting user and one or more other users of the social networking system who are already associated with the organization;
granting the request based at least in part on the social information about the requesting user and one or more other users of the social networking system who are already associated with the organization; and
updating the profile of the requesting user to indicate that the requesting user is associated with the organization if the request is granted.
12. The method of claim 11, wherein the social information comprises information about one or more connections between the requesting user and the one or more other users of the social networking system who are already associated with the organization.
13. The method of claim 12, wherein the request is granted based on an existence of a number of connections between the requesting user and the one or more other users of the social networking system who are already associated with the organization.
14. The method of claim 11, wherein the social information comprises a similarity between two or more users of the social networking system.
15. The method of claim 14, wherein the social information comprises email addresses for the users of the social networking system, and wherein the request is granted based on whether the requesting user has an email address having the same domain as one or more other users of the social networking system who are already associated with the organization.
16. The method of claim 11, wherein the social information comprises confirmations by the users of the social networking system of connections with each other, and wherein the request is granted based on whether a user of the social networking system who is already associated with the organization has confirmed a connection to the requesting user after the request has been made.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. Combination of a damping device with a universal joint hinge for pivotably connecting a first furniture piece to a second furniture piece, the combination comprising a damping housing capable of being secured to one of the furniture pieces, with the damping housing having a cavity containing a damping fluid and a resistance element which is displaceable relative to the damping fluid, wherein the resistance element is coupled with an actuating element extending to an outside of the housing, said actuating element being drivingly connected to the second furniture piece during at least a partial pivoting motion of the two furniture pieces relative to each other and transferring the motion received from the second furniture piece to the resistance element,
wherein the damping device is arranged in the region of a hinge-mounting element of the hinge which pivotally connects the two furniture pieces, the hinge being formed as an articulated joint with mounting elements that are pivotally connected with each other by a universal joint mechanism, and wherein
either the damping housing andor the actuating element acts at least during the damping process on one of the hinge-mounting elements, and wherein the damping housing has an elongated cylindrical cavity filled with the damping fluid, with a piston disposed for longitudinal displacement in the cylindrical cavity as the resistance element, with a piston rod that forms the actuating element acting on the piston, wherein the end of the piston rod facing away from the piston extends outside of the damping housing and wherein the universal joint hinge has two universal joint arms and
wherein a rearward end of one of the universal joint arms, that is oriented towards an interior of one of the furniture pieces, is coupled with the support wall mounting element so as to enable a longitudinal motion by way of a sliding guide and a pivoting motion, wherein the sliding guide is formed by a respective one of two grooves disposed in parallel, spaced-apart side faces of the support wall mounting element that is formed as an elongated body, and a corresponding pin disposed in parallel lateral cheeks of the universal joint arms that protrude over the side faces, wherein the pins engage with the corresponding grooves, and wherein the damping device is arranged in an elongated cavity that is located intermediate between the side faces of the support wall mounting element and is open on the end of the support wall mounting element facing the interior of one of the the one of the furniture pieces, and the grooves that form a portion of the sliding guide are continuous from the side faces of the support wall mounting element to the cavity.
2. Combination of claim 1, wherein the free end of the piston rod of the damping device is secured to the door-leaf-side front end of the elongated cavity, and wherein the other end is moveable in the damping housing implemented as a damping cylinder, and the free inner ends of the pins that protrude from the cheeks of the universal joint arm through the grooves into the elongated cavity are drivingly connected with the damping cylinder.

1461086558-13d43211-a0c9-417c-b276-f8c27d0b08c7

1. A compound of the general formula (I):
wherein
Ring A is bicyclic aromatic heterocycle comprised of (a) pyridine condensed with benzene; or (b) pyridine condensed with monocyclic aromatic heterocycle, and Ring A binds to a sulfonylamino moiety on a carbon atom adjacent to a nitrogen atom of pyridine ring constituting Ring A,
Ring B is (a) monocyclic or bicyclic aromatic hydrocarbon; (b) monocyclic or bicyclic alicyclic hydrocarbon; (c) monocyclic or bicyclic aromatic heterocycle; or (d) monocyclic or bicyclic non-aromatic heterocycle,
Ring C is (a) benzene; or (b) monocyclic aromatic heterocycle,
R1 is (a) hydrogen; (b) optionally substituted alkyl; (c) optionally substituted cycloalkyl; (d) optionally substituted alkoxy; (e) optionally substituted phenyl; (f) halogen; or (g) nitrile,
R2a, R2b, R2c and R2d are each independently (a) hydrogen; (b) optionally substituted alkyl; (c) optionally substituted cycloalkyl; (d) optionally substituted alkoxy; (e) optionally substituted phenyl; (f) optionally substituted monocyclic aromatic heterocyclic group; (g) optionally substituted monocyclic non-aromatic heterocyclic group; (h) halogen; or (i) nitrile,
R3a, R3b, R3c and R3d are each independently (a) hydrogen; (b) optionally substituted alkyl; (c) optionally substituted cycloalkyl; (d) optionally substituted alkoxy; (e) optionally substituted cycloalkoxy; (f) optionally substituted phenyl; (g) optionally substituted monocyclic aromatic heterocyclic group; (h) optionally substituted monocyclic non-aromatic heterocyclic group; (i) optionally substituted phenoxy; (j) halogen; or (k) hydroxy, or

two substituent groups selected from R3a, R3b, R3c and R3d combine each other to form oxo,
R5 and R6 are each independently (a) hydrogen; (b) alkyl; (c) halogenoalkyl; (d) cycloalkyl; or (e) halogenocycloalkyl, or R5 and R6 combine each other at their terminals together with the adjacent carbon atom to form monocyclic alicyclic hydrocarbon,
n is 0, 1 or 2;
X is carboxy, alkoxycarbonyl, hydroxyalkyl, optionally substituted aminocarbonyl, or optionally substituted alkanoyl; or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1, wherein R1 is (a) hydrogen; (b) C1-C6 alkyl which may be optionally substituted by 1 to 7 groups selected from C3-C7 cycloalkyl, C1-C6 alkoxy, halogen, oxo and hydroxy; (c) C3-C7 cycloalkyl which may be optionally substituted by 1 to 7 groups selected from C1-C6 alkyl, C1-C6 alkoxy and halogen; (d) C1-C6 alkoxy which may be optionally substituted by 1 to 7 groups selected from C3-C7 cycloalkyl, C1-C6 alkoxy, halogen and hydroxy; (e) phenyl which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (f) halogen; or (g) nitrile,
R2a, R2b, R2c and R2d are each independently (a) hydrogen; (b) C1-C6 alkyl which may be optionally substituted by 1 to 7 groups selected from C1-C6 alkoxy, C3-C7 cycloalkyl, halogen, oxo and hydroxy; (c) C3-C7 cycloalkyl which may be optionally substituted by 1 to 7 groups selected from C1-C6 alkyl, C1-C6 alkoxy and halogen; (d) C1-C6 alkoxy which may be optionally substituted by 1 to 7 groups selected from C1-C6 alkoxy, C3-C7 cycloalkyl and halogen; (e) phenyl which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, Ci-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (f) 5 to 6-membered monocyclic aromatic heterocyclic group which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl. C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (g) 4 to 7-membered monocyclic non-aromatic heterocyclic group which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (h) halogen; or (i) nitrile,
R3a, R3b, R3c and R3d are each independently (a) hydrogen; (b) C1-C6 alkyl which may be optionally substituted by 1 to 7 groups selected from C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl (in which the cycloalkyl and halogenocycloalkyl may be each independently optionally substituted by 1 to 3 groups selected from C1-C6 alkyl and C1-C 6 halogenoalkyl), C1-C6 alkoxy, C1-C6 halogenoalkoxy, phenyl, 5 to 6-membered monocyclic aromatic heterocyclic group, 4 to 7-membered monocyclic non-aromatic heterocyclic group (in which the phenyl, aromatic heterocyclic group and non-aromatic heterocyclic group may be each independently optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen), halogen, oxo and hydroxy; (c) C3-C7 cycloalkyl which may be optionally substituted by 1 to 7 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy, halogen and hydroxy; (d) C1-C6 alkoxy which may be optionally substituted by 1 to 7 groups selected from C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl (in which the cycloalkyl and halogenocycloalkyl may be each independently optionally substituted by 1 to 3 groups selected from C1-C6 alkyl and C1-C6 halogenoalkyl), C1-C6 alkoxy, C1-C6 halogenoalkoxy, phenyl, 5 to 6-membered monocyclic aromatic heterocyclic group, 4 to 7-membered monocyclic non-aromatic heterocyclic group (in which the phenyl, aromatic heterocyclic group and non-aromatic heterocyclic group may be each independently optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen), halogen and hydroxy; (e) C3-C7 cycloalkoxy which may be optionally substituted by 1 to 7 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy, halogen and hydroxy; (f) phenyl which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (g) 5 to 6-membered monocyclic aromatic heterocyclic group which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (h) 4 to 7-membered monocyclic non-aromatic heterocyclic group which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (i) phenoxy which may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, C3-C7 cycloalkyl, C3-C7 halogenocycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy and halogen; (j) halogen; or (k) hydroxy, or two substituent groups selected from R3a, R3b, R3c and R3d combine each other to form oxo,
R5 and R6 are each independently (a) hydrogen; (b) C1-C6 alkyl; (c) C1-C6 halogenoalkyl; (d) C3-C7 cycloalkyl; or (e) C3-C7 halogenocycloalkyl, or R5 and R5 combine each other at their terminals together with the adjacent carbon atom to form 3 to 7-membered monocyclic alicyclic hydrocarbon,
X is (a) carboxy; (b) C1-C6 alkoxycarbonyl; (c) hydroxy-C1-C6 alkyl; (d) aminocarbonyl wherein a nitrogen atom may be optionally substituted by one group selected from C1-C6 alkyl, C1-C6 alkoxy and nitrite; or (e) C2-C7 alkanoyl which may be optionally substituted by 1 to 3 halogens, or a pharmaceutically acceptable salt thereof.
3. The compound of claim 2, wherein Ring A is quinoline, isoquinoline or pyrrolopyridine, or a pharmaceutically acceptable salt thereof.
4. The compound of claim 2, wherein Ring A, R1, R2a, R2b, R2c and R2d combine each other to form a group of the following formula:
wherein one of Y and Z is CR2d, and the other is a chemical bond, or a pharmaceutically acceptable salt thereof.
5. The compound of claim 4, wherein Ring C is benzene, and X is carboxy and binds to Ring C at 4-position to the aminosulfonyl moiety, or a pharmaceutically acceptable salt thereof.
6. The compound of claim 5, wherein Ring B is (a) monocyclic or bicyclic aromatic hydrocarbon; or (b) monocyclic or bicyclic aromatic heterocycle, and
n is 0 or 1, or a pharmaceutically acceptable salt thereof.
7. The compound of claim 6, wherein a partial structure:
is a group of the following formula (A):
or a pharmaceutically acceptable salt thereof.
8. The compound of claim 6, wherein a partial structure:
is a group of the following formula (B):
or a pharmaceutically acceptable salt thereof.
9. The compound of claim 7 wherein R1 is (a) C1-C6 alkyl which may be optionally substituted by 1 to 7 halogens; (b) C3-C7 cycloalkyl; (c) alkoxy; or (d) halogen,
R2b and R2b are hydrogen,
R2b is (a) hydrogen; (b) C1-C6 alkyl which may be optionally substituted by 1 to 7 halogens; (c) C3-C7 cycloalkyl; or (d) C1-C6 alkoxy,
R3a and R3b are each independently (a) hydrogen; (b) C1-C6 alkyl which may be optionally substituted by 1 to 7 groups selected from C3-C7 cycloalkyl (in which the cycloalkyl may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl and C1-C6 halogenoalkyl), C1-C6 alkoxy, C1-C6 halogenoalkoxy, and halogen; (c) C3-C7 cycloalkyl which may be optionally substituted by 1 to 7 groups selected from C1-C6 alkyl, C1-C6 halogenoalkyl, and halogen; (d) C1-C6 alkoxy which may be optionally substituted by 1 to 7 groups selected from C3-C7 cycloalkyl, C1-C6 alkoxy, C1-C6 halogenoalkoxy, and halogen; or (e) halogen,
R3c and R3d are hydrogen,
R5 and R6 are hydrogen,
n is 1, or a pharmaceutically acceptable salt thereof.
10. The compound of claim 1, which is selected from he group consisting of
4-({(4-methylisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl)benzoic acid;
4-{3-fluoro-4-(trifluoromethoxy)benzyl(4-methylisoquinolin-3-yDaminosulfonyl}benzoic acid;
4-({(1-cyclopropyl-4-methylisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl)-benzoic acid;
4-{4-(1-ethoxy-2,2,2-trifluoro-1-methylethyl)benzyl(4-methylisoquinolin-3-yl)amino-sulfonyl}benzoic acid;
4-(3-methylquinolin-2-yl)4-(trifluoromethoxy)benzylamino}sulfonyl)benzoic acid;
4-{4-fluoro-3-(trifluoromethyl)benzyl(3-methylisoquinolin-2-aminosulfonyl}benzoic acid;
4-{(4-t-butylbenzyl)(4-methylisoquinolin-3-aminosulfony}benzoic acid;
4-{4-(cyclopropylmethyl)benzyl}(4-methylisoquinolin-3-amino}sulfonyl}benzoic acid;
4-{R4-fluoro-3-(trifluoromethyl)benzyly4-methylisoquinolin-3-y0aminosulfonyl}benzoic acid;
4-{(4-methylisoquinolin-3-yl))2-naphthylmethy)aminosulfony}benzoic acid;
4-({(1-methoxy-4-methylisoquinolin-3-yl)4-(trifluoromethoxy)benzyamino}sulfony)-benzoic acid:
4-({(4-chloroisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl)benzoic acid;
4-((4-methylisoquinolin-3-yl)(5,6,7,8-tetrahydronaphthalen-2-ylmethy) aminosulfonyl}-benzoic acid;
4-{(2,3-dihydro-1H-inden-5-yl)methyl)(4-methylisoquinolin-3-yl)aminosulfony}benzoic acid:
4-{(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)methyl(4-methylisoquinolin-3-yl)amino-sulfonyl}benzoic acid;
4-{(2,2-dimethyl-2,3-dihydro-1H-inden-5-yl)mthyl4-methylisoquinolin-3-yl)amino-sulfonyl}benzoic acid;
4-{(3,3-dimethyl-2,3-dihydro-1-benzofuran-6-yl)methyl(4-methylisoquinolin-3-yl)aminosulfonyl}benzoic acid;
4-{(1-benzothiophen-2-yl)methyl(4-methylisoquinolin-3-yl)aminosulfonyl}benzoic acid;
4-({(1,4-dimethylisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl)benzoic acid; and
4-({(4-methylisoquinolin-3-yl)4-(2,2,2-trifluoro-1-methoxy-1-methylethyl)benzylamino}-sulfonyl benzoic acid; or a pharmaceutically acceptable salt thereof.
11. The compound of claim 1, which is selected from the group consisting of 4-({(1-cyclopropyl-4-methylisoquino -y)4-(trifluoromethoxy)benzylamino}sulfonyl)-benzoic acid;
4-({(1-methoxy-4-methylisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl)-benzoic acid;
4-({(1-isopropyl-4-methylisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl)-benzoic acid;
4-{{3-chloro-44cyclopropyl(difluoro)methylbenzyl}(4-methylisoquinolin-3-yl)amino-sulfonyl}benzoic acid;
4-({(4-cyclopropylisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl) benzoic acid;
4-{{3-chloro-4-cyclopropyl(difluoro)methylbenzyl}(1-cyclopropyl-4-methylisoquinolin-3-yl)aminosulfonyl}benzoic acid;
4-{{44cyclopropyl(difluoro)methyl-3-fluorobenzyl}(4-methylisoquinolin-3-yl)amino-sulfonyl}benzoic acid;
4-({4-(trifluoromethoxy)benzyl4-(trifluoromethyl)isoquinolin-3-ylamino}sulfonyl)benzoic acid;
4-R(4-cyclopropylisoquinolin-3-yl){5-(trifluoromethyl)pyridin-2-ylmethyl}amino)sulfonyl-benzoic acid;
4-{{3-chloro-4-cyclopropyl(difluoro)methylbenzyl}(4-cyclopropylisoquinolin-3-yl)amino-sulfonyl}benzoic acid;
4-{{4-cyclopropyl(difluoro)methyl-3-fluorobenzyl}(4-cyclopropylisoquinolin-3-yl)amino-sulfonyl}benzoic acid;
4-({(4-cyclopropylisoquinolin-3-yl)5-(trifluoromethoxy)-2, 3-dihydro-1 H-inden-1-ylamino}sulfonyl)benzoic acid;
4-({{3-chloro-4-cyclopropyl(difluoro)methypenzyl}4-(trifluoromethyl)isoquinolin-3-yl-amino}sulfonyl)benzoic acid; and
4-({{4-cyclopropyl(difluoro)methyl-3-fluorobenzyl}4-(trifluoromethyl)isoquinolin-3-yl-amino}sulfonyl)benzoic acid; or
a pharmaceutically acceptable salt thereof.
12. A pharmaceutical composition, comprising as the active ingredient the compound of claim 1 or a pharmaceutically acceptable salt thereof.
13. The compound of claim 9, wherein Ring B is benzene or pyridine,
R1 is methyl, trifluoromethyl, isopropyl, cyclopropyl, or methoxy,
R3a and R3b are each independently (a) hydrogen; (b) C1-C6 alkyl which may be optionally substituted by 1 to 7 groups selected from C3-C7 cycloalkyl (in which the cycloalkyl may be optionally substituted by 1 to 3 groups selected from C1-C6 alkyl and C1-C6 halogenoalkyl), Ci-C6alkoxy, C1-C6 halogenoalkoxy, and halogen; (c) C3-C7 cycloalkyl; (d) C1-C6alkoxy which may be optionally substituted by 1 to 7 halogens; or (e) halogen, or a pharmaceutically acceptable salt thereof.
14. The compound of claim 1, which is 4-({(1-cyclopropyl-4-methylisoquinolin-3-yl)4-(trifluoromethoxy)benzyamino}sulfonyl)benzoic acid or a pharmaceutically acceptable salt thereof.
15. The compound of claim 1, which is 4-({(1-isopropyl-4-methylisoquinolin-3-yl)4-(trifluoromethoxy)benzyl}amino}sulfonyl)benzoic acid or a pharmaceutically acceptable salt thereof.
16. The compound of claim 1, which is 4-{{3-chloro-4-cyclopropyl(difluoro)methylbenzyl}(4-methylisoquinolin-3-yl)aminosulfonyl}benzoic acid or a pharmaceutically acceptable salt thereof.
17. The compound of claim 1, which is 4-({(4-cyclopropylisoquinolin-3-yl)4-(trifluoromethoxy)benzylamino}sulfonyl) benzoic acid or a pharmaceutically acceptable salt thereof.
18. The compound of claim 1, which is 4-{{3-chloro-4-cyclopropyl(difluoro)methylbenzyl}(1-cyclopropyl-4-methylisoquinolin-3-yl)amino}-sulfonyl}benzoic acid or a pharmaceutically acceptable salt thereof.
19. The compound of claim 1, which is 4-{{4-cyclopropyl(difluoro)methyl-3-fluorobenzyl}(4-methylisoquinolin-3-yl)aminosulfonyl}benzoic acid or a pharmaceutically acceptable salt thereof.
20. The compound of claim 1, which is 4-({4-(trifluoromethoxy)benzyl4-(trifluoromethyl)isoquinolin-3-ylamino}sulfonyl)benzoic acid or a pharmaceutically acceptable salt thereof.
21. The compound of claim 1, which is 4-((4-cyclopropylisoquinolin-3-yl){5-(trifluoromethyl)pyridin-2-ylmethyl}amino)sulfonylbenzoic acid or a pharmaceutically acceptable salt thereof.
22. The compound of claim 1, which is 4-{{4-cyclopropyl(difluoro)methyl-3-fluorobenzyl}(4-cyclopropylisoquinolin-3-yl)aminosulfonyl}benzoic acid or a pharmaceutically acceptable salt thereof.
23. A method for treating a disease or condition selected from chronic pain, cephalalgia, urologic disease, carcinoma, respiratory disease, gastrointestinal disease, psychiatric disease, neurological disease, and dermatosis, the method comprising administering to a subject an effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof.
24. The method of claim 23, wherein the disease or condition is selected from chronic pain and urologic disease.
25. The method of claim 24, wherein the disease or condition is selected from neuropathic pain, nociceptive pain, and mixed pain.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A lens barrel comprising:
a lens holding frame holding a lens group; and
a rack gear provided in the lens holding frame for being moved along a longitudinal direction of a main shaft by a rotation of a lead screw, wherein,
the rack gear includes:
a first tooth abutting with a groove of the lead screw,
a second tooth adjoining the first tooth and being disposed at an interval which is a groove pitch of the lead screw, such that the second tooth does not abut with the groove of the lead screw, and
a flat abutting portion abutting with a crest of at least one ridge of the lead screw.
2. The lens barrel of claim 1, wherein, along the longitudinal direction of the main shaft, the first tooth, the second tooth, and the abutting portion are disposed in this order.
3. The lens barrel of claim 1, wherein the rack gear includes only one said first tooth.
4. The lens barrel of claim 1, wherein,
a plurality of guide holes are formed in the lens holding frame;
where the longitudinal direction of the main shaft defines a height direction, the first tooth is located at a height corresponding to a substantial center between a first guide hole and a second guide hole among the plurality of guide holes; and
the second tooth is located closer to an end than is the first tooth.
5. The lens barrel of claim 1, wherein,
a guide hole is provided in the lens holding frame, the guide hole being penetrated by the main shaft; and
a first guide hole is formed in the lens holding frame, the first guide hole being penetrated by a sub-shaft; and
in a cross section taken orthogonal to the longitudinal direction of the main shaft, a point of abutment between the rack gear and the lead screw, the main shaft, and the sub-shaft are disposed in this order.
6. The lens barrel of claim 5, further comprising
a rack spring provided on the lens holding frame for energizing the rack gear against the lead screw, wherein
along a direction which is orthogonal to a direction of a force generated by the rack spring between the rack gear and the lead screw and which is orthogonal to the longitudinal direction of the main shaft, the point of abutment between the rack gear and the lead screw, the main shaft, and the sub-shaft are disposed in this order.
7. The lens barrel of claim 1, wherein,
the main shaft has a circular cross section;
a cross section of the guide hole taken orthogonal to the longitudinal direction of the main shaft includes at least two linear portions; and
the main shaft is in contact with the two linear portions.
8. The lens barrel of claim 7, wherein,
a plurality of said guide holes are formed in the lens holding frame;
each of the plurality of guide holes includes at least two linear portions;
the two linear portions of each of the plurality of guide holes are in contact with the main shaft;
each of the plurality of guide holes includes a corner portion corresponding to the two linear portions; and
the respective corner portions of the plurality of guide holes are oriented in mutually different directions.
9. The lens barrel of claim 7, wherein a corner portion of the guide hole corresponding to the two linear portions is oriented in a direction of a force acting on the guide hole.
10. The lens barrel of claim 9, wherein,
two guide holes are formed in the lens holding frame; and
the respective corner portions of the two guide holes are oriented in directions which are 45\xb0 apart.
11. The lens barrel of claim 7, wherein the cross section of the guide hole is a triangle or a rectangle.
12. The lens barrel of claim 6, wherein two linear portions are provided at positions of the plurality of guide holes which receive reaction forces occurring in the lens holding frame when the rack spring energizes the rack gear against the lead screw.
13. The lens barrel of claim 12, wherein the two linear portions are energized against the main shaft due to the reaction forces.
14. The lens barrel of claim 9, wherein,
each of the plurality of guide holes includes a corner portion corresponding to the two linear portions; and
the corner portion of each of first and second guide holes is oriented in a direction of a force which the rack gear applies to the lead screw.
15. An imaging apparatus comprising the lens barrel of claim 1.